Skip to main content
. 2020 Jun 1;6(3):305–308. doi: 10.1016/j.artd.2020.04.007

Table 2.

Comparison of perioperative outcomes between matched cohorts.

Study variable Chloroprocaine group (n = 37) Bupivacaine group (n = 37) P value
Hospital length of stay (days, SD)
 Total (inpatients and ambulatory) 0.9 (0.4) 1.2 (0.7) .03∗
 Inpatients only 1.1 (0.3) 1.3 (0.6) .05∗
Postoperative disposition
 Inpatient stay (#, %) 28 (75.7) 31 (83.8)
 Ambulatory surgery (#, %) 9 (24.3) 6 (16.2) .39
Operative time (min, SD) 68.2 (16.1) 83.6 (20.8) .03∗
Estimated blood loss (mL, SD) 184.7 (59.3) 218.9 (66.0) .02∗
PACU length of stay (min, SD)
 Total (inpatients and ambulatory) 139.4 (103.8) 194.9 (124.0) .04∗
Discharge disposition
 Home (#, %) 37 (100) 33 (89.2)
 Post–acute care institution (#, %) 0 (0) 4 (10.8) .04∗
Intraoperative hypotension
 Yes (#, %) 22 (59.5) 31 (83.8)
 No (#, %) 15 (40.5) 6 (16.2) .02∗
Need for intraoperative vasopressor bolus
 Yes (#, %) 24 (64.9) 28 (75.7)
 No (#, %) 13 (35.1) 9 (24.3) .31
Missed PT session
 Yes (#, %) 1 (2.7) 5 (13.5)
 No (#, %) 36 (97.3) 32 (86.5) .09
PONV
 Yes (#, %) 5 (13.5) 11 (29.7)
 No (#, %) 32 (86.5) 26 (70.3) .09

PACU, postanesthesia care unit; PONV, postoperative nausea and vomiting; PT, physical therapy; SD, standard deviation.

Values marked with an asterisk (∗) represent statistical significance, P < .05.